Advisor Group, Inc. - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 60 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$0
-100.0%
4000.0%0.00%
Q3 2019$1,000
-50.0%
4000.0%0.00%
Q2 2019$2,0000.0%4000.0%0.00%
Q1 2019$2,0000.0%4000.0%0.00%
Q4 2018$2,000
-99.1%
400
-97.6%
0.00%
-100.0%
Q3 2018$225,000
+21.0%
16,609
+5.5%
0.00%
-33.3%
Q2 2018$186,000
+1966.7%
15,742
+1867.8%
0.00%
Q1 2018$9,000
+80.0%
8000.0%0.00%
Q4 2017$5,000
-28.6%
8000.0%0.00%
Q3 2017$7,0008000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 12,025,999$66,263,0002.30%
Abingworth LLP 250,000$1,375,0001.02%
Tekla Capital Management LLC 1,466,368$8,080,0000.31%
Rock Springs Capital Management LP 875,000$4,821,0000.28%
QVT Financial LP 1,360,647$6,940,0000.22%
Vident Investment Advisory, LLC 232,641$1,282,0000.13%
Hillhouse Capital Management 1,190,476$6,560,0000.13%
Orbimed Advisors 1,914,660$10,550,0000.12%
Granite Investment Partners, LLC 195,571$1,078,0000.07%
Monashee Investment Management LLC 25,000$138,0000.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders